CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men

被引:24
|
作者
Zhang, L. [1 ,2 ]
Miyaki, K. [3 ]
Wang, W. [2 ]
Muramatsu, M. [1 ,2 ]
机构
[1] Tokyo Med & Dent Univ, Dept Mol Epidemiol, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan
[2] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Biostat, Beijing, Peoples R China
[3] Keio Univ, Sch Med, Dept Prevent Med Cerebrovasc Dis, Shinjuku Ku, Tokyo, Japan
基金
中国国家自然科学基金;
关键词
CYP3A5; polymorphism; salt intake; blood pressure; interaction; SEQUENCE DIVERSITY; GENOTYPE; HUMANS; SODIUM; HYPERTENSION; ASSOCIATION; EXPRESSION; POTASSIUM; ADULTS; GENE;
D O I
10.1038/jhh.2009.74
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The cytochrome P-450 3A5 (CYP3A5) gene has recently been implicated in renal sodium reabsorption and blood pressure regulation. The genetic effect of CYP3A5*1 (expressor) and *3 (reduced-expressor) variants on blood pressure has been studied in African Americans and Caucasians, but not yet in the Asian population. In this cross-sectional study, 238 Japanese male workers were examined to determine whether CYP3A5 *1*3 affects the blood pressure level, taking daily salt intake into account as a potential gene-environment interaction. The A6986G polymorphism was determined by melting curve analysis, and the salt intake level was inferred from spot urine specimen by calculating 24-h urinary sodium excretion. CYP3A5 *1*3 per se had no association with systolic blood pressure (SBP) and only a weak association was detected for diastolic blood pressure (DBP) (*1/*1 vs *3/*3, P=0.038), which was strengthened after adjustment with age and body mass index (*1/*1 vs*3/*3, P=0.007; *1/*1 vs*1/*3, P=0.045). Significant interactions between the genotype and salt intake were observed in both SBP (P=0.046) and DBP (P=0.003). SBP and DBP were significantly associated with the level of salt intake in*3/*3 (P<0.001) but not in *1 carriers. *1carrier had higher blood pressure than *3/*3, but only in those with low salt intake. These results suggest that CYP3A5 variants may be a determinant of salt sensitivity of blood pressure in Japanese men. Journal of Human Hypertension (2010) 24, 345-350; doi:10.1038/jhh.2009.74; published online 8 October 2009
引用
收藏
页码:345 / 350
页数:6
相关论文
共 50 条
  • [31] Impact of population admixture on the distribution of the CYP3A5*3 polymorphism
    Suarez-Kurtz, Guilherme
    Perini, Jamila A.
    Bastos-Rodrigues, Luciana
    Pena, Sergio D. J.
    Struchiner, Claudio
    PHARMACOGENOMICS, 2007, 8 (10) : 1299 - 1306
  • [32] Genotyping of the A6986G polymorphism of CYP3A5
    Weiss, J
    Haefeli, WE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 663 - 663
  • [33] Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin
    Kolovou, Genovefa
    Ragia, Georgia
    Kolovou, Vana
    Mihas, Constantinos
    Katsiki, Niki
    Vasiliadis, Ioannis
    Mavrogeni, Sophie
    Vartela, Vassiliki
    Tavridou, Anna
    Manolopoulos, Vangelis G.
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2014, 8 : 12 - 17
  • [34] Influence of CYP3A5 Polymorphism on the Pharmacokinetics of Psychiatric Drugs
    Ragia, Georgia
    Dahl, Marja-Liisa
    Manolopoulos, Vangelis G.
    CURRENT DRUG METABOLISM, 2016, 17 (03) : 227 - 236
  • [35] Association of CYP3A5 genotypes with blood pressure and renal function in African families
    Bochud, Murielle
    Eap, Chin B.
    Elston, Robert C.
    Bovet, Pascal
    Maillard, Marc
    Schild, Laurent
    Shamlaye, Conrad
    Burnier, Michel
    JOURNAL OF HYPERTENSION, 2006, 24 (05) : 923 - 929
  • [36] Role Of Cyp3a5*1 for Salt-Sensitive Blood Pressure Regulation in Young Male Normotensive Caucasian Individuals
    Bolbrinker, Juliane
    Beige, Joachim
    Thomas, Alexander
    Bauer, Steffen
    Sharma, Arya M.
    Deter, Hans-Christian
    Kreutz, Reinhold
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 519 - 520
  • [37] Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population
    Fukuen, S
    Fukuda, T
    Maune, H
    Ikenaga, Y
    Yamamoto, I
    Inaba, T
    Azuma, J
    PHARMACOGENETICS, 2002, 12 (04): : 331 - 334
  • [38] Polymorphism of CYP11B2 determines salt sensitivity in Japanese
    Iwai, Naoharu
    Kajimoto, Kazuaki
    Tomoike, Hitonobu
    Takashima, Naoyuki
    HYPERTENSION, 2007, 49 (04) : 825 - 831
  • [39] No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam
    Tomalik-Scharte, D.
    Doroshyenko, O.
    Kirchheiner, J.
    Jetter, A.
    Lazar, A.
    Klaassen, T.
    Frank, D.
    Wyen, C.
    Faetkenheuer, G.
    Fuhr, U.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (10) : 1033 - 1035
  • [40] CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients
    Fan, Zhirong
    Zheng, Deqiang
    Wen, Xinmei
    Shen, Faxiu
    Lei, Lin
    Su, Shengyao
    Zhang, Shu
    Liu, Qing
    Zhang, Xueping
    Lu, Yan
    Di, Li
    Shen, Xin-Ming
    Da, Yuwei
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 355